Quantcast
 

Search

T.H. v. Novartis

Ninety percent of the prescription drugs consumed in the United States are generic forms of brand-name drugs. But under U.S. Supreme Court case law, generic drug companies can’t be sued for failing to warn consumers of the dangers of their drug, no matter how inadequate...

Williams v. Boehringer (Zantac)

Public Justice is co-counsel in this 11th Circuit appeal of a decision in a federal MDL dismissing nationwide failure-to-warn and design defect claims against the manufacturers and sellers of the pharmaceutical product Zantac and its generic forms.  The appeal raises an  important issue of first...

40 Years 40 Cases

Four Decades of Justice As Public Justice’s 40th year came to a close in 2022, we launched our #40Cases40Years campaign, highlighting our top 40 cases on our social media feeds. Learn more about some of our favorite cases on this timeline spanning all four decades. 1983Liuzzo v....

‘Judicial Hellholes’: The Best Legal Joke of 2018

Here’s a good riddle: What do you call a court system that holds a drug manufacturer accountable for causing brain damage to children by failing to warn of its drug’s dangers? There are lots of good answers: Fair. Just. True to America's principles. The American Tort Reform Foundation’s answer is: “Judicial Hellhole #1.”

Public Justice Fights for Prescription Drug Victims in California Supreme Court

Generic drugs, anyone? If you care about access to justice, you might want to just say no. In a suit we've filed on behalf of twin boys, the California Supreme Court case will determine whether victims of inadequately labeled generic drugs can seek compensation for their injuries from brand-name drug manufacturers. The stakes couldn’t be higher: over 80 percent of all drugs consumed in this country are generic.
Skip to content